Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Clinical trial NCT04985357 · WITHDRAWN

Trial details

NCT number: NCT04985357
Sponsor: Travera Inc
Status: WITHDRAWN
Study type: OBSERVATIONAL

Stage III Breast Cancer Stage IV Breast Cancer Stage III Lung Cancer Stage IV Lung Cancer AML Multiple Myeloma in Relapse Carcinoma Carcinoma, Pancreatic Carcinoma of Lung Carcinoma, Non-Small-Cell Lung Carcinoma Breast Carcinoma Prostate

Start date: 2024-11-01
Primary completion: 2028-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.